Ae Wealth Management LLC Blueprint Medicines Corp Transaction History

Ae Wealth Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 18, 2022	SELL	$54.1 - $110.08 $394,064 - $801,822	-7,284 Closed	0 $0
Q4 2021 Jan 20, 2022	BUY	$94.25 - $115.99 $686,517 - $844,871	7,284 New	7,284 $780,000
Q4 2020 Feb 01, 2021	SELL	$92.08 - $124.48 $662,883 - $896,131	-7,199 Closed	0 $0
Q3 2020 Nov 06, 2020	SELL	$66.45 - $92.7 $100,339 - $139,977	-1,510 Reduced 17.34%	7,199 $667,000
Q2 2020 Aug 05, 2020	BUY	$57.09 - $79.27 $497,196 - $690,362	8,709 New	8,709 $679,000

351

60.3M

2.25M

1.18M

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.4B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

Get notified when there are updates to the investment portfolio of Ae Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ae Wealth Management LLC with notifications on news.